GnRH antagonists, Imminent ovarian hyperstimulation syndrome, In-vitro fertilization, Ovarian hyperstimulation syndrome
dx.doi.org/10.1093/humrep/13.3.573, hdl.handle.net/1765/65052
Human Reproduction
Department of Gynaecology & Obstetrics

de Jong, D, Macklon, N.S, Mannaerts, B.M, Coelingh-Bennink, H.J.T, & Fauser, B.C.J.M. (1998). High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in-vitro fertilization. Human Reproduction, 13(3), 573–575. doi:10.1093/humrep/13.3.573